$7.68
-0.15-1.92%
At close: -
$7.68
0.000.00%
After Hours: 4:56 PM EDT
Zevra Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Zevra Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.69 | $-0.42 | -64.3 % |
Q2 | 2024-08-13 | $-0.48 | $-0.44 | -9.09 % |
Q1 | 2024-05-08 | $-0.40 | $-0.48 | 16.7 % |
Q4 | 2024-03-28 | $-0.40 | $-0.27 | -48.1 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $3.70M | $4.87M | -24.1 % |
Q2 | 2024-08-13 | $4.45M | $4.41M | 0.88 % |
Q1 | 2024-05-08 | $3.43M | $3.76M | -8.91 % |
Q4 | 2024-03-28 | $13.22M | $11.74M | 12.6 % |
Zevra Therapeutics (ZVRA) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.69, which missed the estimate of $-0.42.
The Actual Revenue was $3.7M, which missed the estimate of $4.9M.
Browse earnings estimates, EPS, and revenue on all stocks.